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Abstract: Four new tetrahydrofuran lignans, schpropinrins A–D (1–4), together with five known ones, were isolated from the 
leaves and stems of Schisandra propinqua var. sinensis. Their structures, including absolute configurations, were characterized by 
means of spectroscopic analysis and ECD calculation. Compounds 1–4 featured a ketal or hemiketal substructure at C-7 and all of 
the isolates were tested for their anti-HIV integrase activity. 
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Introduction 
Phytochemical investigations on species of the family  
Schisandraceae have revealed that they are rich sources of 
lignans, which possessed various beneficial pharmacological 
effects, such as antitumor,1 cytotoxic,2–4 anti-HIV,5,6  
antioxidative,7,8 antihepatitis,9 and hepatoprotective effects.1 
Schisandra propinqua var. sinensis, popularly known as 
“tie-gu-san” in the Shennongjia district of mainland China, is 
used as folk medicine for the treatment of arthritis, traumatic 
injury, gastralgia, angeitis, and other related diseases.10 Aiming
at the discovery of biologically active natural products,  
phytochemical research on this plant was carried out. As a 
result, four new tetrahydrofuran lignans, schpropinrins A–D 
(1–4), together with five known ones, were isolated and their 
absolute structures were elucidated by extensive spectroscopic 
studies and quantum chemical calculation (Fig. 1). The five 
known tetrahydrofuran lignans were identified to be henricine 
A (5),11 ganschisandrin (6),12 2R-(2α,3α,4α,5β)-4,4'-
(tetrahydro-3,4-dimethyl-2,5-furandiyl)bis(2-methoxy-phenol) 
(7),13 chicanine (8),14 neoolivil (9).15 All of the compounds 
were evaluated in an anti-HIV integrase DNA binding assay. 
 
Results and Discussion 
Schpropinrin A (1) was obtained as yellow oil and its 
molecular formula of C22H26O7 was established from HREIMS 
([M]+, m/z 402.1688) and 13C NMR (DEPT) spectroscopic 
data, indicating 10 degrees of unsaturation. The IR spectrum 
showed the presence of hydroxyl group (3443 cm–1) and 
aromatic moieties (1611, 1517, 1489 cm–1), and a very intense 
absorption band at 1138 cm–1 suggesting a C-O-C functional 
group. Its 1H NMR spectrum (Table 2) showed proton signals 
corresponding to an oxybenzyl methine (δH 4.85, d, 10.1 Hz, 
1H) and two methyl protons (δH 1.30, s, 3H; 0.95, d, 6.8 Hz, 
3H), which suggested that 1 was an asymmetric tetrahydro-
furan lignan.16,17 The chemical shifts observed for aromatic 
protons at δH 7.06 (overlapped, 1H), 6.83 (d, 8.0 Hz, 1H), 7.08 
(overlapped, 1H), 7.00 (s, 1H), 6.85 (d, 8.0 Hz, 1H) and 6.95 
(d, 8.0 Hz, 1H), associated with the presence of intense signals 
corresponding to two methoxy groups (δH 3.91, s, 3H; δH 3.88, 
s, 3H) and a methylenedioxy moiety (5.98, s, 2H) indicated the 








1 R1 = Me, R2 = Me
3 R1 = H, R2 = Me









































6 R1 = Me, R2 = Me
7 R1 = H, R2 = H  
Figure 1.  Structures of compounds 1–9 
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1,3,4-trisubstituted one). The 13C NMR spectrum (Table 1) 
corroborated the assignments made for the structural 
determination of both aromatic rings. As expected, the two 
trisubstituted aromatic rings displayed the chemical shifts of 
six methines for aromatic carbons (δC 107.9, 107.9, 122.0, 
110.2, 110.7, 120.2). 1H-1H COSY correlation of H-5 (δH 6.83) 
with H-6 (δH 7.08) and HMBC correlations of both H-2  
(δH 7.06) and H-5 with C-3 and C-4 suggested that another 
aromatic ring was also 1,3,4-trisubstituted (Fig. 2). 
Furthermore, HMBC correlations from H-7 to C-2, C-1, and 
C-6 and from H-2 and H-6 to C-7, located the two aromatic 
rings to the tetrahydrofuran ring (Fig. 2). HMBC correlations 
from the methylenedioxy protons to C-3 and C-4 and from the 
methoxy protons to C-3 and C-4, suggested that two methoxy 
groups were attached at C-3 and C-4, while methylenedioxy 
moiety attached at C-3 and C-4, respectively. The proposal 
was confirmed by the ROESY correlations of methoxy protons 
(δH 3.91) with H-2, of another methoxy protons (δH 3.88) with 
H-5 (Fig. 2). Except for the presence of the above two 
methoxy groups, a special upfield signal belonging to another 
methoxy group (δH 3.23, δC 50.2) was observed in 1H and 13C 
NMR spectra. This upfield shifted methoxy group was 
deduced to be attached at C-7 by HMBC correlation observed 
from the methoxy signal to C-7 and the relative downfield 
shift of C-7 (δC 111.6, s). In addition, HMBC correlations (Fig. 
2) from H-9, H-9, and H-7 to the oxygenated quaternary 
carbon C-8 (δC 82.3, s), along with the analysis of its 
molecular formula, indicated that C-8 of 1 was substituted by a 
hydroxyl group. The relative configurations of 1 were 
established on the basis of ROESY spectrum. The key 
correlations from H-9' to H-7' and H-9 revealed that they were 
cofacial and the correlation between H-6' and OMe-7 indicated 
that they were on the other side. Thus, the relative 
configuration of 1 was determined. H-7', H-9', and H-9 were 
arbitrarily defined as β-orientation, and accordingly, H-8' and 
OMe-7 were assigned as α-orientation (Fig. 3). Therefore, the 
structure of 1 was established. 
Schpropinrin B (2), obtained as yellow oil, had the 
molecular formula C22H26O7, as derived from HREIMS at m/z 
402.1673 [M]+, which was almost the same as that of 1. 
Detailed comparison of the NMR data of 2 with those of 1 
disclosed that the main structural difference between them was 
likely to be the locations of the substitutions in aromatic rings. 
HMBC correlations from the methylenedioxy protons to C-3 
and C-4, from H-7 to C-1, C-2, and C-6, and from H-2 and 
H-5 to C-3 and C-4 established that the methylenedioxy 
group was located between C-3 and C-4. Furthermore, in 
HMBC spectrum, the correlations from H-2 and H-6 to C-7, 
from two methoxy groups to C-3 and C-4, and from H-2 and 
H-5 to C-3 and C-4, together with the ROESY correlations of 
one methoxy group (δH 3.80) with H-2, of another methoxy 
group (δH 3.79) with H-5, confirmed that two methoxy groups 
were located at C-3 and C-4, respectively. In the ROESY 
experiment, H-9 showed strong correlations with H-9 and H-
7, and H-7 with H-2, indicating β-orientation of the H-9, H-
9, and H-7. OMe-7 (δH 3.16, s, 3H) showed correlations with 
H-2 and H-6, indicating its α-orientation. 
Schpropinrin C (3) was obtained as yellow amorphous 
powder. Its molecular formula, C21H24O7, was determined by 
the molecular ion peak [M]+ in the positive HREIMS at m/z 
388.1514 (calcd 388.1522), indicating 10 degrees of 
unsaturation. Detailed comparison of 1H and 13C NMR data of 
3 with those of 1 showed they are structurally similar. The 
major difference was the disappearance of a methoxy signal  
(δC 55.8, q) in 3. HMBC correlations from H-7 to C-2, and C-
6, from H-2 and H-5 to C-3 and C-4, and from the methoxy 
protons (δH 3.92, s, 3H) to C-4, together with the correlations 
of the methoxy protons with H-2 in the ROESY spectrum, 
determined that the hydroxyl group and the methoxy group 
Table 1. 13C NMR spectroscopic assignments of compounds  
1–4a,b 
position 1 2 3 4
1 129.7 s 130.1 s 130.3 s 133.2 s 
2 107.9 d 113.3 d 108.9 d 110.0 d 
3 147.8 s 150.1 s 146.4 s 147.5 s 
4 147.9 s 149.6 s 146.6 s 148.1 s 
5 107.9 d 111.7 d 108.0 d 107.7 d
6 122.0 d 121.8 d 121.8 d 121.2 d 
7 111.6 s 112.7 s 112.1 s 108.0 s 
8 82.3 s 82.6 s 82.3 s 81.8 s 
9 19.8 q 19.8 q 19.8 q 19.8 q 
1 133.6 s 137.1 s 133.0 s 133.9 s 
2 110.2 d 108.1 d 109.7 d 110.7 d 
3 149.1 s 148.1 s 147.9 s 149.0 s 
4 148.8 s 148.8 s 147.8 s 148.7 s 
5 110.7 d 108.5 d 114.0 d 108.4 d 
6 120.2 d 122.0 d 120.9 d 119.6 d
7 87.6 d 88.1 d 87.7 d 87.4 d 
8 48.6 d 50.0 d 48.6 d 48.6 d 
9 8.3 q 8.6 q 8.3 q 8.3 q 
3-OCH2O- 101.2 t 56.0 q (3-OCH3) 101.2 t 101.2 t 
4-OCH2O- 55.9 q (4-OCH3) 
3-OCH3 55.7 q 102.0 t (-OCH2O-) 55.8 q 55.8 q 
4-OCH3 55.9 q  55.9 q 
7-OCH3 50.2 q 50.2 q 50.2 q  
aRecorded in CD3Cl; bRecorded at 100 MHz. 
 
Figure 2.  Selected HMBC ( ) and 1H-1H COSY ( ) 
correlations of 1 and 4 
 
1                                                        4 
Figure 3.  Selected ROESY ( ) correlations of 1 and 4 
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were located at C-4 and C-3, respectively. The relative 
configurations were established to be the same as compound 1 
by analysis of the ROESY experiment. 
Schpropinrin D (4), yellow oil, had the formula C21H24O7 
for HREIMS m/z 388.1520 [M]+, suggesting 10 degrees of 
unsaturation. Comparison of 1H and 13C NMR data of 4 with 
those of 1 suggested that 4 was structurally related to 1. The 
difference between 1 and 4 could be explained by the 
replacement of a methoxy group in 1 by a OH group in 4, 
which was further confirmed by the conducting of sets of 2D 
NMR experiments (1H-1H COSY, HSQC, HMBC, and 
ROESY spectra) and the relative upfield shift of C-7 (δC 108.0, 
s) in 4 (Figs. 2 and 3). 
On the basis of the relative configuration was established, 
the quantum chemical calculation of electronic circular 
dichroism (ECD) spectrum was carried out for schpropinrin D 
(4) using the time dependent DFT (TDDFT) method with the 
B3LYP-SCRF/6-31+G(d,p)//B3LYP/6-31G(d) level.18,19 The 
calculated ECD spectrum for the 7S, 8R, 7'R, 8'S enantiomer 
correspond with the experimental ECD curve (Fig. 4). In 
addition, the experimental ECD spectra of compounds 1–3 
were nearly identical with that of 4, suggesting that the 
stereochemistry of compounds 1–3 were also with 7S, 8R, 7'R, 
8'S configurations. 
Compounds 1–9 at a concentration of 25 μM were evaluated 
for their ability to inhibit HIV-1 IN DNA binding activity in 
vitro using the method previously used.20 All of the  
compounds were inactive at the concentration tested. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured with a Horiba SEPA-300 polarimeter. UV spectrum 
were obtained using a Shimadzu UV-2401A spectrophoto-
meter. A Tenor 27 spectrophotometer was used for scanning 
IR spectroscopy with KBr pellets. 1D and 2D NMR spectra 
were recorded on Bruker AM-400, DRX-500 and Avance III-
600 spectrometers. Unless otherwise specified, chemical shifts 
() were expressed in ppm with reference to the solvent signals. 
Mass spectra were performed on a VG Autospec-3000 
spectrometer at 70 eV. Column chromatography was 
performed using silica gel (200–300 mesh, Qing-dao Marine 
Chemical, Inc., Qingdao, China). Semi-preparative HPLC was 
performed on an Agilent 1100 liquid chromatography with a 
Zorbax SB-C18, 9.4 mm  25 cm column. Preparative HPLC 
was performed on a Shimadzu LC-8A preparative liquid 
chromatography with a Shimadzu PRC-ODS (K) column. 
Fractions were monitored by TLC and spots were visualized 
by heating the silica gel plates sprayed with 10% H2SO4 in 
EtOH. 
 
Plant Material. The leaves and stems of S. propinqua var. 
sinensis were collected in Shennongjia, Hubei Province, China, 
in September 2010. The specimen was identified by Prof. 
Heng Li and a voucher specimen (No. KIB 2010-09-15) has 
been deposited at the State Key Laboratory of Phytochemistry 
and Plant Resources in West China, Kunming Institute of 
Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The plant material of S.  
propinqua var. sinensis (15 kg) was ground and exhaustively 
extracted with Me2CO-H2O (V/V = 7:3) at room temperature. 
The solvent was evaporated in vacuo, and the crude extract 
was dissolved in H2O and partitioned with EtOAc. The EtOAc 
portion (480 g) was chromatographed on a silica gel column 
being eluted with CHCl3-Me2CO (1:0, 9:1, 8:2, 2:1, 1:1, and 
0:1) to afford fractions I–VII. Fraction II (32 g) was applied to 
RP-18, eluted with a MeOH-H2O (40%–100%) gradient  
system, to afford five fractions. Fraction II-4 (6.3 g) were  
further repeatedly chromatographed on silica gel, Sephadex 
LH-20, and finally by semi-preparative HPLC to yield 1 (9 
Table 2. 1H NMR spectroscopic assignments of compounds 1–4a,b 
position 1 2 3 4 
2 7.06c 7.07 (d, 7.0) 7.05c 7.08 (s) 
5 6.83 (d, 8.0) 6.92c 6.84 (d, 8.0) 6.82c 
6 7.08c  7.04 (d, 7.0) 7.08c 7.08c 
9 1.30 (s) 1.31 (s) 1.30 (s) 1.29 (s) 
2 7.00 (s) 6.95 (s) 6.98 (s)  
5 6.85 (d, 8.0) 6.83 (d, 7.0) 6.91c 6.84c 
6 6.95 (d, 8.0) 6.91 (d, 7.0) 6.91c 6.94 (d, 8.2) 
7 4.85 (d, 10.1) 4.83 (d, 10.2) 4.85 (d, 10.2) 4.84 (d, 10.2) 
8 2.45 (m) 2.35 (m) 2.45 (m) 2.45 (m) 
9 0.95 (d, 6.8) 0.90 (d, 6.8) 0.95 (d, 6.8) 0.94 (d, 6.8) 
OCH2O-3,4 5.98 (s) 6.00 (s) (OCH2O-3,4) 5.98 (s) 5.96 (s) 
7-OCH3 3.23 (s) 3.16 (s) 3.22 (s)  
3-OCH3 3.91 (s) 3.80 (s) (3-OCH3) 3.92 (s) 3.90 (s) 
4 -OCH3 3.88 (s) 3.79 (s) (4-OCH3)  3.87 (s) 
aRecorded in CD3Cl; bRecorded at 400 MHz; coverlapped 
 
Figure 4.  Calculated and experimental ECD spectra of 4 
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mg), 2 (6 mg), 3 (10 mg), 5 (20 mg), 6 (11 mg), 7 (4 mg) and 
8 (14 mg). Compounds 4 (7 mg) and 9 (3 mg) were purified 
from Fraction III (14 g) through successively subjected to  
silica gel, RP-18 and Sephadex LH-20. 
 
Schpropinrin A (1): yellow oil; [α] 24D   + 66.0 (c 0.14, 
MeOH); UV (MeOH) max (log ) 282 (3.11), 231 (3.43), 204 
(3.96) nm; CD (MeOH) max (ᇞ) 286 (+ 0.97), 234 (+ 2.87), 
205 (+ 20.40) nm; IR (KBr) max 3443, 2961, 2934, 2879, 1611, 
1517, 1489, 1463, 1439, 1250, 1138 cm–1; 1H and 13C NMR 
data, see Tables 1 and 2; HREIMS m/z 402.1688 [M]+  (calcd 
for C22H26O7, 402.1679). 
 
Schpropinrin B (2): yellow oil; [α] 24D   + 76.8 (c 0.20, 
MeOH); UV (MeOH) max (log ) 282 (3.11), 231 (3.41), 205 
(3.98) nm; CD (MeOH) max (ᇞ) 286 (+ 0.74), 234 (+ 2.23), 
205 (+ 15.25) nm; IR (KBr) max 3444, 2962, 2935, 2879, 
1608, 1515, 1490, 1462, 1444, 1250, 1138 cm–1; 1H and 13C 
NMR data, see Tables 1 and 2; HREIMS m/z 402.1673 [M]+  
(calcd for C22H26O7, 402.1679). 
 
Schpropinrin C (3): yellow amorphous powder; [α]25D   + 
41.3 (c 0.30, MeOH); UV (MeOH) max (log ) 283 (2.99), 229 
(3.28), 202 (3.90) nm; CD (MeOH) max nm (ᇞ) 282 (+ 0.62), 
232 (+ 2.04), 205 (+ 14.16); IR (KBr) max 3442, 2963, 2935, 
1614, 1516, 1489, 1463, 1437, 1250, 1135 cm–1; 1H and 13C 
NMR data, see Tables 1 and 2; HREIMS m/z 388.1514 [M]+  
(calcd for C21H24O7, 388.1522). 
 
Schpropinrin D (4): yellow oil; [α]24D   + 1.4 (c 0.23, MeOH); 
UV (MeOH) max (log ) 282 (3.17), 231 (3.45), 204 (3.90) nm; 
CD (MeOH) max (ᇞ) 282 (+ 0.65), 233 (+ 1.92), 205 (+ 
13.48) nm; IR (KBr) max 3449, 2964, 2936, 1599, 1511, 1489, 
1463, 1443, 1249, 1127 cm–1; 1H and 13C NMR data, see 
Tables 1 and 2; HREIMS m/z 388.1520 [M]+ (calcd for 
C21H24O7, 388.1522). 
 
ECD Calculation. The theoretical calculations of 
compound 4 were performed using Gaussian 09.21 The 
conformers were optimized at the B3LYP/6-31G (d) level. 
Room temperature equilibrium populations were calculated 
according to Boltzmann distribution law. The theoretical 
calculation of ECD was performed using time dependent 
Density Functional Theory (TDDFT)18,19 at the B3LYP/6-
31G+(d, p) level in MeOH with PCM model and in the gas 
phase, respectively. The ECD spectra of compound 4 were 
obtained by weighing the Boltzmann distribution rate of each 
geometric conformation. 
 
ECD Simulation. The ECD spectra are simulated by 













   
The σ represented the width of the band at 1/e height, and 
ΔEi and Ri are the excitation energies and rotational strengths 
for transition i, respectively. σ = 0.20 eV and Rvelocity have been 
used in this work. 
 
Microplate-Based Assay for HIV-1 IN-DNA Binding: 
IN-DNA binding assays were performed using purified  
recombinant integrase protein as previously described.20  
Briefly, IN (500 nM) in PBS (pH 7.4) was loaded into Nunc 
FluoroNunc microplate wells (200 μL per well) and the plates 
were incubated at 4 °C for overnight. Unbound proteins were 
removed by three washes in 200 μL PBS per well (pH 7.4). 
The plates were then blocked with 200 μL PBS/well containing
2% BSA (wt/vol) for 2 h and washed three times in PBS. 
Drugs were prepared as a 5X work solution at 125 μM in  
binding buffer (20 mM MOPS [pH 7.2], 20 mM NaCl, 5 mM 
DTT, 7.5 mM MgCl2) and 20 μL each drug was added to each 
well (a final concentration of 25 μM). Then, 80 μL of a 5'-
rhodamine-labeled LTR duplex (20 nM) in binding buffer 
were added to the wells (total vol. of 100 μL per well). Wells 
containing 25 μL of binding buffer, but without drug, were 
used as positive controls (no drug). The plates were incubated 
at room temperature for 1 h. After removal of the reaction 
mixtures by rapid inversion, the plates were then washed three 
times in PBS. Finally, 100 μL PBS was added to each well, 
and fluorescence was measured in a FLUOstar Optima plate 
reader (BMG Labtech) at excitation and emission wavelengths 
of 544 and 590 nm, respectively. All measurements were  
performed in triplicate, and experiments were repeated at least 
three times. The percentages of inhibition of IN DNA binding 
activity by each drug were calculated by comparing activities 
relative to the positive control without drug (set as 100%). 
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